https://magazine.pharmamkt.net/2019/05/15/sensorion-announces-the-positive-data-safety-monitoring-board-dsmb-review-and-continuation-of-the-phase-2-clinical-trial-for-sens-111-in-acute-unilateral-vestibulopathy-auv/
Sensorion Announces the Positive Data Safety Monitoring Board (DSMB) Review and Continuation of the Phase 2 Clinical Trial for SENS-111 in Acute Unilateral Vestibulopathy (AUV)